BriaCell Therapeutics Corp.
Last updated September 27, 2026
Organization details
- Legal name
- BriaCell Therapeutics Corp.
- Former names
- Ansell Capital Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- British Columbia, Canada
- Headquarters city
- West Vancouver
- Headquarters country
- Canada
- Fiscal year end
- July
- Ticker symbol
- BCTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001610820
Board of directors
-
Marc Lustig · DirectorSince 2024
Director election results
Annual meeting of January 30, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2024 | Marc Lustig Director, 10% owner | Open-market purchase | +902,935 | $2.22 | $2,004,516 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.